S. Mercadante et Rk. Portenoy, Opioid poorly-responsive cancer pain. Part 3. Clinical strategies lo improve opioid responsiveness, J PAIN SYMP, 21(4), 2001, pp. 338-354
Citations number
188
Categorie Soggetti
General & Internal Medicine","Neurosciences & Behavoir
Some pain syndromes may be difficult to treat due to a poor response to opi
oids. This situation demands a range of alternative measures, including the
use of adjuvant drugs with independent effects, such as antidepressants, s
odium channel-blocking agents, steroids and anti-inflammatory drugs (NSAIDs
); drugs that reduce opioid side effects; and drugs that enhance analgesia
produced by opioids, such as N-methyl-D-aspartate (NMDA) antagonists, calci
um channel antagonists, and clonidine. Other approaches, including opioid t
rials, neural blockade when necessary and psychological interventions, also
may be useful. (C) U.S. Cancer Pain Relief Committee, 2001.